Fluorescence metalosensors provide a means to detect iron in biological systems that is versatile, economical, sensitive and of a high-throughput nature. They rely on relatively high-affinity ironbinding carriers conjugated to highly fluorescent probes that undergo quenching after metal complexation. Metal specificity is determined by probes containing either an iron-binding moiety of high affinity (type A) or of relatively lower affinity (type B) used in combination with a strong specific iron chelator. Due to the heterogeneous nature of biological systems, the apparent metalbinding affinity and complexation stoichiometry ought to be specifically defined. Fluoresceinated moieties coupled to metal-binding cores detect Fe at sub-micromolar concentrations and even submicrolitre volumes (i.e. cells). Although an ideal probe should also be specific for a particular oxidation state of iron, in physiological conditions that property might be difficult to attain. Quantification of labile iron in cells has relied on the ability of permeant iron chelators to restore the fluorescence of probes quenched by intracellular Fe. Modern design of probes aims to (a) improve probe targeting to specific cell compartments and (b) create probes that respond to metal binding by signal enhancement.
Introduction
Iron plays a pivotal rule in a number of metabolical processes, but its abnormal accumulation in pathological states might cause severe damage arising from metal-catalysed oxidations. In biological systems the major fraction of cell iron is proteinbound; however, a minor cell fraction is of labile character, serving as a chemically accessible reservoir for metabolic reactions as well as a potential source for generation of noxious radicals [l] .
T h e quantification of labile iron in both intracellular or extracellular compartments can be achieved by a number of physical or chemical methods. These have certain shortcomings since they either require the destruction of the sample, lack the requisite sensitivity or are not easily adaptable for high-throughput assays. Fluorescence detection of iron (FDI) compares favourably with those methods in simplicity, sensitivity, price and the potential for automation.
FDI by metalosensors
T h e underlying concept of FDI is the recognition of the metal by means of a probe built with a chemical receptor coupled to a signalling moiety (the fluorophore). Upon metal complexation, the fluorescence signal F,, is usually deactivated, yielding -AF = F,, -F. If the absolute -AF results from high-affinity complexation, it can be directly equated with quencher concentration, irrespective of the probe levels.
Two categories of probe can be defined on the basis of iron-binding properties ( Figure 1 ) : type A comprises highly specific iron chelators, usually transferrin or microbial siderophores such as desferrioxamine (DFO), and type B comprises chelators of relatively lower metal-binding affinity and specificity, such as EDTA, diethylenetriaminepenta-acetic acid (DTPA) or phenanthroline (phen). For both types, the apparent binding affinity for the metal in the biological milieu should be at least in the lower micromolar range. T h e stoichiometry of the metal-chelator complex can be obtained from fluorimetric titrations in solution. Probes with chelating moieties that have low denticity might be advantageous in terms of metal sensitivity, since binding of a single metal ion might evoke a signal change in more than one fluorophore. However, possible formation of sub-stoichiometric complexes in biological fluids might limit their usage. Selectivity for a particular metal valency might not always be achievable by metalo-sensing probes in physiological conditions, despite the fact that most of the known iron chelators exhibit demonstrably higher affinity for Fe(II1) than Fe(I1). This is because, under those conditions, Fe(I1) will oxidize upon complex formation [2] , and vice versa, Fe(III), in extreme conditions, might be reduced to Fe( I I) upon binding to phen-containing probes [3].
Type A probes can be used for direct assessment of iron in biological systems by means of a simple calibration curve of -AF versus [Fe] . Since iron is the most abundant 3d element in organisms, interference by other potential quenchers is unlikely or will be insignificant. As F D I based on type B probes might be susceptible to interferences by other transition metals, quantification of labile iron is approached and usually achieved by additional application of a chelator that reverses the signal contributed by the complexed iron. T h e speed and amplitude of the fluorescence recovery vary with the nature of probes and the experimental conditions (Figure 1 
FDI in labile iron pools (LIPS)
T h e quantification of L I P in extracellular fluids can be used for assessment of iron egress from cells or for estimating labile iron in the plasma of ironoverloaded patients (e.g. haemochromatosis and P-thalassemic patients, etc.) [4] . 
Introduction
Copper is an essential micronutrient for all living organisms. Because copper can readily gain and lose an electron it is a cofactor of oxidases, monoand di-oxygenases (e.g. amine oxidase, ammonia mono-oxygenase, ceruloplasmin, lysyl oxidase) and of enzymes involved in the elimination of superoxide radicals (e.g. superoxide dismutase, ascorbate oxidase). It is also an important component of electron transfer in respiration, where it is found in cytochrome oxidase, the terminal complex of the respiratory chain. In chloroplasts copper is incorporated into plastocyanin, an electron transporter in photosynthesis. Yet, copper is potentially toxic at high concentration because it can generate reactive oxygen that damages cellular components, interferes with cellular transport Key words Arabrdopsrs, homoeostasis, transport 'To whom correspondence should be addressed (e-mail wintz@uclink berkeley edu)
2002 Biochemical Society

732
processes and produces changes in the concentrations of essential metabolites. As a result, uptake and homoeostasis of this metal ion must be strictly regulated. Multiple mechanisms exist to control metal toxicity, including regulated uptake from the environment, intracellular chelation, efflux from cells, intracellular sequestration in organelles and neutralization of copper-induced free radicals. T h e intracellular concentration of free copper is undetectable in normal physiological conditions to prevent toxicity. Therefore, cells require small receptor proteins called metallochaperones that bind copper (overcoming the high thermodynamic capacity for non-specific copper chelation in the cytoplasm) and facilitate copper transfer to specific partners. Copper chaperones were first characterized in Succharomyces cerevisiae and the three known chaperones are CCS, ATXl and COX17. CCS delivers copper to Cu/Zn superoxide dismutase [l] and ATXl delivers copper to the secretory pathway via CCC2, a copper-transporting P-type ATPase 
A T X I homologues
CCH, an Arabidopsis homologue of the yeast ATXl copper chaperone, has been identified by
